Private equity firm Carlyle Group is to acquire up to 74% equity stake in animal health-focused pharma company SeQuent Scientific, for ₹15.8 billion (US$210 million).
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.